{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T04:49:51Z","timestamp":1794372591622,"version":"4.9.0"},"reference-count":162,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Inflammatory bowel disease [IBD] is often diagnosed in patients during their reproductive years. It is crucial that both healthcare providers and patients are adequately informed to avoid misguided decisions regarding family planning.<\/jats:p>\n               <jats:p>One of the most important aspects during conception and pregnancy is to maintain disease remission, as disease activity is associated with adverse pregnancy outcomes. Apart from methotrexate, most conventional drugs used in IBD are considered low risk during conception and pregnancy. For newer agents, evidence is still limited. If needed, surgery must not be postponed and should ideally be performed in specialized centres.<\/jats:p>\n               <jats:p>In most patients, delivery should be vaginal except for patients with complex perianal disease, with an ileoanal pouch anastomosis, or if there is an obstetric contraindication.<\/jats:p>\n               <jats:p>In children exposed to biological treatments during pregnancy, the risk of infections appears to be low, and psychomotor development is probably not affected. Regarding immunizations, the standard vaccination schedule for inactivated vaccines should be followed for children exposed to biologics in utero. In the case of live vaccines, such as rotavirus, decisions should be individualized and take into consideration the risk\u2013benefit ratio, particularly in developing countries.<\/jats:p>\n               <jats:p>In this review, we provide a comprehensive and updated overview of aspects related to fertility, pregnancy, breastfeeding, and the impact on the care of children born to mothers with IBD. Both the available evidence and areas of uncertainty are discussed, with the goal of assisting healthcare professionals caring for IBD patients during this important stage of their lives.<\/jats:p>","DOI":"10.1093\/ecco-jcc\/jjae048","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T16:10:57Z","timestamp":1730304657000},"page":"ii16-ii30","source":"Crossref","is-referenced-by-count":19,"title":["Navigating Reproductive Care in Patients With Inflammatory Bowel Disease: A Comprehensive Review"],"prefix":"10.1093","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9009-9635","authenticated-orcid":false,"given":"Paula","family":"Sousa","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Hospital S\u00e3o Teot\u00f3nio \u2013 Unidade Local de Sa\u00fade D\u00e3o Laf\u00f5es , Viseu ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2090-3445","authenticated-orcid":false,"given":"Javier P","family":"Gisbert","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Inflammatory Bowel Disease Unit, Hospital Universitario de La Princesa, Instituto de Investigaci\u00f3n Sanitaria Princesa [IIS-Princesa], Universidad Aut\u00f3noma de Madrid [UAM], Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas [CIBEREHD] , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3070-8950","authenticated-orcid":false,"given":"Mette","family":"Julsgaard","sequence":"additional","affiliation":[{"name":"Department of Hepatology & Gastroenterology, Aarhus University Hospital , Aarhus ,","place":["Denmark"]},{"name":"Centre for Molecular Prediction of Inflammatory Bowel Disease [PREDICT], Department of Clinical Medicine, Aalborg University , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Philipp","family":"Selinger","sequence":"additional","affiliation":[{"name":"Gastroenterology, Leeds Teaching Hospitals NHS Trust , Leeds ,","place":["UK"]},{"name":"University of Leeds , Leeds ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9275-4242","authenticated-orcid":false,"given":"Mar\u00eda","family":"Chaparro","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Inflammatory Bowel Disease Unit, Hospital Universitario de La Princesa, Instituto de Investigaci\u00f3n Sanitaria Princesa [IIS-Princesa], Universidad Aut\u00f3noma de Madrid [UAM], Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas [CIBEREHD] , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"2024103011390287800_CIT0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjac115","article-title":"European Crohn\u2019s and Colitis guidelines on sexuality, fertility, pregnancy, and lactation","volume":"17","author":"Torres","year":"2023","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0002","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the selecting therapeutic targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for Treat-to-Target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"2024103011390287800_CIT0003","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/ecco-jcc\/jjac170","article-title":"Fertility and assisted reproductive technologies outcomes of women with non-surgically managed inflammatory bowel diseases: a systematic review","volume":"17","author":"Vieujean","year":"2023","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0004","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/ibd\/izy345","article-title":"Inflammatory bowel diseases were associated with risk of sexual dysfunction in both sexes: a meta-analysis","volume":"25","author":"Zhao","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011390287800_CIT0005","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/ibd\/izy348","article-title":"A meta-analysis of sexual function in patients with inflammatory bowel disease: examining a small piece of the puzzle","volume":"25","author":"Friedman","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011390287800_CIT0006","doi-asserted-by":"crossref","first-page":"526","DOI":"10.14309\/ajg.0000000000000515","article-title":"Men with inflammatory bowel disease: sexual function, fertility, medication safety, and prostate cancer","volume":"115","author":"Hammami","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"2024103011390287800_CIT0007","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.3390\/jcm12134267","article-title":"Factors associated with family planning status and voluntary childlessness in women of childbearing age with inflammatory bowel diseases","volume":"12","author":"Selinger","year":"2023","journal-title":"J Clin Med"},{"key":"2024103011390287800_CIT0008","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/ecco-jcc\/jjaa047","article-title":"Knowledge and attitudes towards pregnancy in females with inflammatory bowel disease: an international, multi-centre study","volume":"14","author":"Laube","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0009","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/ibd.20839","article-title":"Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions","volume":"15","author":"Mountifield","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011390287800_CIT0010","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1136\/gut.27.7.821","article-title":"European survey of fertility and pregnancy in women with Crohn\u2019s disease: a case control study by European collaborative group","volume":"27","author":"Mayberry","year":"1986","journal-title":"Gut"},{"key":"2024103011390287800_CIT0011","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.cgh.2019.08.031","article-title":"Comparison of time to pregnancy in women with and without inflammatory bowel diseases","volume":"18","author":"Friedman","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2024103011390287800_CIT0012","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/apt.13354","article-title":"Decreased fertility rates in 9639 women diagnosed with inflammatory bowel disease: a United Kingdom population-based cohort study","volume":"42","author":"Ban","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011390287800_CIT0013","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/apt.16984","article-title":"Minor impact on fertility in men with inflammatory bowel disease: a national cohort study from Sweden","volume":"56","author":"Druvefors","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011390287800_CIT0014","doi-asserted-by":"crossref","first-page":"e33113","DOI":"10.1097\/MD.0000000000033113","article-title":"Inflammatory bowel disease can reduce ovarian reserve function in women: a systematic review and meta-analysis","volume":"102","author":"Guo","year":"2023","journal-title":"Medicine (Baltim)"},{"key":"2024103011390287800_CIT0015","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.3390\/nu14122423","article-title":"Crohn\u2019s disease and female infertility: can nutrition play a supporting role","volume":"14","author":"Vincenti","year":"2022","journal-title":"Nutrients"},{"key":"2024103011390287800_CIT0016","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cgh.2018.04.001","article-title":"Paternal disease activity is associated with difficulty in conception among men with inflammatory bowel diseases","volume":"17","author":"Ananthakrishnan","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2024103011390287800_CIT0017","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/ecco-jcc\/jjy198","article-title":"Semen quality and sperm DNA integrity in patients with severe active inflammatory bowel disease and effects of tumour necrosis factor-alpha inhibitors","volume":"13","author":"Grosen","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0018","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/ecco-jcc\/jjad079","article-title":"Female and male fertility after colectomy and reconstructive surgery in inflammatory bowel diesase: a national cohort study from Sweden","volume":"17","author":"Druvefors","year":"2023","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0019","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/jcag\/gwaa010","article-title":"Surgery for inflammatory bowel disease has unclear impact on female fertility: a Cochrane collaboration systematic review","volume":"4","author":"Lee","year":"2021","journal-title":"J. Can Assoc Gastroenterol"},{"key":"2024103011390287800_CIT0020","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2174\/1871530319666190313112110","article-title":"Inflammatory bowel disease therapies adversely affect fertility in men \u2013 a systematic review and meta-analysis","volume":"19","author":"Banerjee","year":"2019","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"2024103011390287800_CIT0021","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/ibd\/izab205","article-title":"Low-dose methotrexate therapy does not affect semen parameters and sperm DNA","volume":"28","author":"Grosen","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011390287800_CIT0022","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/AOG.0000000000001936","article-title":"Risk of adverse pregnancy outcome after paternal exposure to methotrexate within 90 days before pregnancy","volume":"129","author":"Eck","year":"2017","journal-title":"Obstet Gynecol"},{"key":"2024103011390287800_CIT0023","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.reprotox.2017.10.004","article-title":"Birth outcomes after preconception paternal exposure to methotrexate: a nationwide cohort study","volume":"74","author":"Winter","year":"2017","journal-title":"Reprod Toxicol"},{"key":"2024103011390287800_CIT0024","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/MIB.0000000000001064","article-title":"The influence of methotrexate treatment on male fertility and pregnancy outcome after paternal exposure","volume":"23","author":"Grosen","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011390287800_CIT0025","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.12998\/wjcc.v11.i8.1730","article-title":"Pregnancy and medications for inflammatory bowel disease: an updated narrative review","volume":"11","author":"Akiyama","year":"2023","journal-title":"World J Clin Cases"},{"key":"2024103011390287800_CIT0026","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1007\/s12325-022-02168-4","article-title":"MANTA and MANTA-RAy: rationale and design of trials evaluating effects of filgotinib on semen parameters in patients with inflammatory diseases","volume":"39","author":"Hellstrom","year":"2022","journal-title":"Adv Ther"},{"key":"2024103011390287800_CIT0027","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/ard-2023-224017","article-title":"Effects of filgotinib on semen parameters and sex hormones in male patients with inflammatory diseases: results from the phase 2, randomised, double-blind, placebo-controlled MANTA and MANTA-RAy studies","volume":"82","author":"Reinisch","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2024103011390287800_CIT0028","doi-asserted-by":"crossref","first-page":"S364","DOI":"10.1016\/S0016-5085(17)31470-1","article-title":"Role of assisted reproductive technologies in inflammatory bowel disease: results from the PIANO registry","volume":"152","author":"Kathpalia","year":"2017","journal-title":"Gastroenterology"},{"key":"2024103011390287800_CIT0029","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.14309\/ajg.0000000000001537","article-title":"Assisted reproductive technology in Crohn\u2019s disease and ulcerative colitis: a systematic review and meta-analysis","volume":"116","author":"Laube","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"2024103011390287800_CIT0030","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1080\/09513590.2019.1684465","article-title":"Infertile patients with inflammatory bowel disease have comparable in vitro fertilization clinical outcomes to the general infertile population","volume":"36","author":"Hernandez-Nieto","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"2024103011390287800_CIT0031","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00404-020-05644-w","article-title":"Pregnancy outcomes in women with inflammatory bowel disease who successfully conceived via assisted reproduction technique","volume":"302","author":"Lavie","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"2024103011390287800_CIT0032","doi-asserted-by":"crossref","first-page":"17562848221087543","DOI":"10.1177\/17562848221087543","article-title":"Gastroenterology team members\u2019 knowledge and practices with fertility therapy for women with inflammatory bowel disease","volume":"15","author":"Laube","year":"2022","journal-title":"Therap Adv Gastroenterol"},{"key":"2024103011390287800_CIT0033","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/ajg.2015.50","article-title":"Familial risk of inflammatory bowel disease: a population-based cohort study 1977\u20132011","volume":"110","author":"Moller","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"2024103011390287800_CIT0034","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/bmj.312.7023.95","article-title":"Genetics versus environment in inflammatory bowel disease: results of a British twin study","volume":"312","author":"Thompson","year":"1996","journal-title":"BMJ"},{"key":"2024103011390287800_CIT0035","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1080\/003655200451207","article-title":"Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study","volume":"35","author":"Orholm","year":"2000","journal-title":"Scand J Gastroenterol"},{"key":"2024103011390287800_CIT0036","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40291-023-00678-7","article-title":"The genetics of inflammatory bowel disease","volume":"28","author":"El Hadad","year":"2023","journal-title":"Mol Diagn Ther"},{"key":"2024103011390287800_CIT0037","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1053\/gast.1996.v111.pm8780562","article-title":"Familial aggregation in Crohn\u2019s disease: increased age-adjusted risk and concordance in clinical characteristics","volume":"111","author":"Peeters","year":"1996","journal-title":"Gastroenterology"},{"key":"2024103011390287800_CIT0038","first-page":"14","article-title":"Familial and ethnic risk in inflammatory bowel disease","volume":"31","author":"Santos","year":"2018","journal-title":"Ann Gastroenterol"},{"key":"2024103011390287800_CIT0039","first-page":"361","article-title":"Conjugal inflammatory bowel disease: a systematic review and European survey","volume":"34","author":"Costa-Santos","year":"2021","journal-title":"Ann Gastroenterol"},{"key":"2024103011390287800_CIT0040","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/ibd\/izy085","article-title":"Determinants of IBD heritability: genes, bugs, and more","volume":"24","author":"Turpin","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011390287800_CIT0041","doi-asserted-by":"crossref","first-page":"100884","DOI":"10.1016\/j.eclinm.2021.100884","article-title":"Early life exposures and the risk of inflammatory bowel disease: systematic review and meta-analyses","volume":"36","author":"Agrawal","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2024103011390287800_CIT0042","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/ecco-jcc\/jjac111","article-title":"Risk factors for developing inflammatory bowel disease within and across families with a family history of IBD","volume":"17","author":"Torres","year":"2023","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0043","doi-asserted-by":"crossref","first-page":"511","DOI":"10.14309\/ajg.0000000000002180","article-title":"The contribution of genetic risk and lifestyle factors in the development of adult-onset inflammatory bowel disease: a prospective cohort study","volume":"118","author":"Sun","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"2024103011390287800_CIT0044","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s10620-020-06480-3","article-title":"Identifying patient priorities for preconception and pregnancy counseling in IBD","volume":"66","author":"Aboubakr","year":"2021","journal-title":"Dig Dis Sci"},{"key":"2024103011390287800_CIT0045","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/ecco-jcc\/jjac189","article-title":"Multidisciplinary perinatal care in IBD","volume":"17","author":"Godny","year":"2023","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0046","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4292\/wjgpt.v7.i3.361","article-title":"Infertility in men with inflammatory bowel disease","volume":"7","author":"Shin","year":"2016","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"2024103011390287800_CIT0047","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/00000658-200006000-00017","article-title":"Functional outcomes after ileal pouch-anal anastomosis for chronic ulcerative colitis","volume":"231","author":"Farouk","year":"2000","journal-title":"Ann Surg"},{"key":"2024103011390287800_CIT0048","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1053\/j.gastro.2018.12.022","article-title":"Inflammatory bowel disease in pregnancy clinical care pathway: a report from the American Gastroenterological Association IBD parenthood project working group","volume":"156","author":"Mahadevan","year":"2019","journal-title":"Gastroenterology"},{"key":"2024103011390287800_CIT0049","doi-asserted-by":"crossref","first-page":"7343","DOI":"10.3390\/jcm12237343","article-title":"Monitoring of inflammatory bowel disease in pregnancy: a review of the different modalities","volume":"12","author":"Al-Jabri","year":"2023","journal-title":"J Clin Med"},{"key":"2024103011390287800_CIT0050","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1007\/s10620-017-4635-6","article-title":"Gestational weight gain: a new factor influencing pregnancy outcomes in women with inflammatory bowel disease","volume":"62","author":"Friedman","year":"2017","journal-title":"Dig Dis Sci"},{"key":"2024103011390287800_CIT0051","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/MCG.0000000000001244","article-title":"Noninvasive methods for assessing inflammatory bowel disease activity in pregnancy: a systematic review","volume":"53","author":"Tandon","year":"2019","journal-title":"J Clin Gastroenterol"},{"key":"2024103011390287800_CIT0052","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1055\/s-0041-1739567","article-title":"Endoscopy in pregnancy: a systematic review","volume":"12","author":"Pal","year":"2021","journal-title":"Journal of Digestive Endoscopy"},{"key":"2024103011390287800_CIT0053","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0054","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1097\/AOG.0000000000002355","article-title":"Committee Opinion No. 723: guidelines for diagnostic imaging during pregnancy and lactation","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"2024103011390287800_CIT0055","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/ecco-jcc\/jjaa082","article-title":"Monitoring inflammatory bowel disease in pregnancy using gastrointestinal ultrasonography","volume":"14","author":"Flanagan","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0056","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/jcag\/gwy062","article-title":"The role of bowel ultrasound in detecting subclinical inflammation in pregnant women with Crohn\u2019s disease","volume":"2","author":"Leung","year":"2019","journal-title":"J. Can. Assoc. Gastroenterol."},{"key":"2024103011390287800_CIT0057","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1055\/s-0029-1243968","article-title":"European Society of Gastrointestinal Endoscopy (ESGE): recommendations (2009) on clinical use of video capsule endoscopy to investigate small-bowel, esophageal and colonic diseases","volume":"42","author":"Ladas","year":"2010","journal-title":"Endoscopy"},{"key":"2024103011390287800_CIT0058","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.reprotox.2007.11.010","article-title":"Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis","volume":"25","author":"Rahimi","year":"2008","journal-title":"Reprod Toxicol"},{"key":"2024103011390287800_CIT0059","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/gut.52.2.243","article-title":"Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study","volume":"52","author":"N\u00f8rg\u00e5rd","year":"2003","journal-title":"Gut"},{"key":"2024103011390287800_CIT0060","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","article-title":"Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies","volume":"62","author":"Park-Wyllie","year":"2000","journal-title":"Teratology"},{"key":"2024103011390287800_CIT0061","doi-asserted-by":"crossref","first-page":"585.e1","DOI":"10.1016\/j.ajog.2007.05.046","article-title":"Maternal corticosteroid use and orofacial clefts","volume":"197","author":"Carmichael","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"2024103011390287800_CIT0062","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.reprotox.2003.10.007","article-title":"Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study","volume":"18","author":"Gur","year":"2004","journal-title":"Reprod Toxicol"},{"key":"2024103011390287800_CIT0063","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1503\/cmaj.101063","article-title":"Corticosteroid use during pregnancy and risk of orofacial clefts","volume":"183","author":"Hviid","year":"2011","journal-title":"CMAJ"},{"key":"2024103011390287800_CIT0064","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12916-023-02817-7","article-title":"Adverse birth outcomes and early-life infections after in utero exposure to corticosteroids for inflammatory bowel disease: a Danish nationwide cohort study","volume":"21","author":"J\u00f8lving","year":"2023","journal-title":"BMC Med"},{"key":"2024103011390287800_CIT0065","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/ecco-jcc\/jjv006","article-title":"Intrapartum corticosteroid use significantly increases the risk of gestational diabetes in women with inflammatory bowel disease","volume":"9","author":"Leung","year":"2015","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0066","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1136\/gutjnl-2021-325317","article-title":"Exposure to corticosteroids in pregnancy is associated with adverse perinatal outcomes among infants of mothers with inflammatory bowel disease: results from the PIANO registry","volume":"71","author":"Odufalu","year":"2022","journal-title":"Gut"},{"key":"2024103011390287800_CIT0067","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ibd.20640","article-title":"Budesonide induction and maintenance therapy for Crohn\u2019s disease during pregnancy","volume":"15","author":"Beaulieu","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011390287800_CIT0068","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/01443615.2012.716106","article-title":"The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy","volume":"33","author":"Hutson","year":"2013","journal-title":"J Obstet Gynaecol"},{"key":"2024103011390287800_CIT0069","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/ecco-jcc\/jjac183","article-title":"Exposure to thioguanine during 117 pregnancies in women with inflammatory bowel disease","volume":"17","author":"Crouwel","year":"2023","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S2468-1253(19)30186-4","article-title":"De-escalation of immunomodulator and biological therapy in inflammatory bowel disease","volume":"5","author":"Chapman","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2024103011390287800_CIT0071","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/ecco-jcc\/jju006","article-title":"The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease","volume":"9","author":"van der Woude","year":"2015","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0072","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00054725-199603000-00006","article-title":"Safety of drug therapy for inflammatory bowel disease in pregnant and nursing women","volume":"2","author":"Connell","year":"1996","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011390287800_CIT0073","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/jcm13010034","article-title":"Reproductive safety issues of novel small molecules for the treatment of inflammatory bowel disease: a systematic review","volume":"13","author":"Monfared","year":"2024","journal-title":"J Clin Med"},{"key":"2024103011390287800_CIT0074","article-title":"Xeljanz (tofacitinib) summary of product characteristics (gb)","author":"Pfizer","year":"2023","journal-title":"Fertility, Pregnancy and Lactation"},{"key":"2024103011390287800_CIT0075","article-title":"Jyseleca\u00ae","author":"File. GDO","year":"2023","journal-title":"Pregnancy Outcomes in Patients Exposed to Filgotinib."},{"key":"2024103011390287800_CIT0076","volume-title":"RINVOQ (upadacitinib)-summary of product characteristics","author":"Agency","year":"2019"},{"key":"2024103011390287800_CIT0077","volume-title":"Filgotinib summary of product characteristics","author":"Agency"},{"key":"2024103011390287800_CIT0078","article-title":"Ozanimod medical information","author":"Bristol-Meyer-Squibb","year":"2023","journal-title":"Pregnancy Outcomes in Patients Exposed to Ozanimod."},{"key":"2024103011390287800_CIT0079","author":"Pfizer","year":"2023"},{"key":"2024103011390287800_CIT0080","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ajg.2008.71","article-title":"Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy","volume":"104","author":"Kane","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"2024103011390287800_CIT0081","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0897.1996.tb00172.x","article-title":"Evolution of maternofetal transport of immunoglobulins during human pregnancy","volume":"36","author":"Malek","year":"1996","journal-title":"Am J Reprod Immunol"},{"key":"2024103011390287800_CIT0082","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1016\/S0264-410X(03)00334-7","article-title":"Placental transport of immunoglobulin G","volume":"21","author":"Simister","year":"2003","journal-title":"Vaccine"},{"key":"2024103011390287800_CIT0083","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/ecco-jcc\/jjac093","article-title":"Timing of live attenuated vaccination in infants exposed to infliximab or adalimumab in utero: a prospective cohort study in 107 children","volume":"16","author":"Liu","year":"2022","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0084","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cgh.2012.11.011","article-title":"Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease","volume":"11","author":"Mahadevan","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2024103011390287800_CIT0085","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2016.04.002","article-title":"Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection","volume":"151","author":"Julsgaard","year":"2016","journal-title":"Gastroenterology"},{"key":"2024103011390287800_CIT0086","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/apt.14040","article-title":"The effects of pregnancy on the pharmacokinetics of infliximab and adalimumab in inflammatory bowel disease","volume":"45","author":"Seow","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011390287800_CIT0087","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/2050640620964619","article-title":"Infliximab clearance decreases in the second and third trimesters of pregnancy in inflammatory bowel disease","volume":"9","author":"Gri\u0161i\u0107","year":"2021","journal-title":"United European Gastroenterol J"},{"key":"2024103011390287800_CIT0088","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/apt.16102","article-title":"Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure","volume":"52","author":"Flanagan","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011390287800_CIT0089","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cgh.2020.09.021","article-title":"Biologics for inflammatory bowel disease and their safety in pregnancy: a systematic review and meta-analysis","volume":"20","author":"Nielsen","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2024103011390287800_CIT0090","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ajg.2017.501","article-title":"Long-term safety of in utero exposure to anti-TNF\u03b1 drugs for the treatment of inflammatory bowel disease: results from the multicenter european TEDDY study","volume":"113","author":"Chaparro","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"2024103011390287800_CIT0091","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1136\/gutjnl-2019-319129","article-title":"Health outcomes of 1000 children born to mothers with inflammatory bowel disease in their first 5 years of life","volume":"70","author":"Kanis","year":"2021","journal-title":"Gut"},{"key":"2024103011390287800_CIT0092","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1053\/j.gastro.2020.11.038","article-title":"Pregnancy and neonatal outcomes after fetal exposure to biologics and thiopurines among women with inflammatory bowel disease","volume":"160","author":"Mahadevan","year":"2021","journal-title":"Gastroenterology"},{"key":"2024103011390287800_CIT0093","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/s41395-018-0176-7","article-title":"Continuous anti-TNF\u03b1 use throughout pregnancy: possible complications for the mother but not for the fetus. A retrospective cohort on the French National Health Insurance Database (EVASION)","volume":"113","author":"Luu","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"2024103011390287800_CIT0094","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/ibd\/izz110","article-title":"Anti-TNF therapy in pregnant women with inflammatory bowel disease: effects of therapeutic strategies on disease behavior and birth outcomes","volume":"26","author":"Julsgaard","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011390287800_CIT0095","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/gutjnl-2018-316023","article-title":"Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease","volume":"68","author":"Zeissig","year":"2019","journal-title":"Gut"},{"key":"2024103011390287800_CIT0096","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1111\/jgh.15574","article-title":"Systematic review and meta-analysis: Safety of vedolizumab during pregnancy in patients with inflammatory bowel disease","volume":"36","author":"Bell","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"2024103011390287800_CIT0097","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/apt.15539","article-title":"Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study","volume":"51","author":"Moens","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011390287800_CIT0098","doi-asserted-by":"crossref","first-page":"468","DOI":"10.14309\/ajg.0000000000002553","article-title":"Maternal and neonatal outcomes in vedolizumab and ustekinumab exposed pregnancies: results from the PIANO registry","volume":"119","author":"Chugh","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"2024103011390287800_CIT0099","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/apt.16593","article-title":"Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort study","volume":"54","author":"Julsgaard","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011390287800_CIT0100","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1093\/ecco-jcc\/jjac086","article-title":"Safety of ustekinumab and vedolizumab during pregnancy-pregnancy, neonatal, and infant outcome: a prospective multicentre study","volume":"16","author":"Mitrova","year":"2022","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0101","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.3389\/fimmu.2018.01700","article-title":"Effects of anti-integrin treatment with vedolizumab on immune pathways and cytokines in inflammatory bowel diseases","volume":"9","author":"Rath","year":"2018","journal-title":"Front Immunol"},{"key":"2024103011390287800_CIT0102","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/apt.16739","article-title":"Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero","volume":"55","author":"Flanagan","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011390287800_CIT0103","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2024.01.008","article-title":"Infant ustekinumab clearance, risk of infection, and development after exposure during pregnancy","author":"Julsgaard","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2024103011390287800_CIT0104","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/apt.17224","article-title":"Ustekinumab during pregnancy in patients with inflammatory bowel disease: a prospective multicentre cohort study","volume":"56","author":"Avni-Biron","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011390287800_CIT0105","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/apt.16192","article-title":"Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study","volume":"53","author":"Wils","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011390287800_CIT0106","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/apt.16960","article-title":"Pregnancy outcomes following periconceptional or gestational exposure to ustekinumab: review of cases reported to the manufacturer\u2019s global safety database","volume":"56","author":"Mahadevan","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011390287800_CIT0107","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41575-023-00758-3","article-title":"Inflammatory bowel disease in pregnancy and breastfeeding","volume":"20","author":"Brondfield","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2024103011390287800_CIT0108","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/ecco-jcc\/jjac050","article-title":"Surgery due to inflammatory bowel disease during pregnancy: mothers and offspring outcomes from an ECCO Confer Multicentre Case Series [Scar Study]","volume":"16","author":"Chaparro","year":"2022","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0109","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1177\/2050640620921060","article-title":"Surgery for Crohn\u2019s disease during pregnancy: a nationwide survey","volume":"8","author":"Germain","year":"2020","journal-title":"United European Gastroenterol J"},{"key":"2024103011390287800_CIT0110","first-page":"bcr-2017","article-title":"Salvage therapy for acute severe ulcerative colitis during pregnancy","volume":"2018","author":"Raval","year":"2018","journal-title":"BMJ Case Reports"},{"key":"2024103011390287800_CIT0111","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/codi.13413","article-title":"Surgical management of complicated and medically refractory inflammatory bowel disease during pregnancy","volume":"19","author":"Killeen","year":"2017","journal-title":"Colorectal Dis"},{"key":"2024103011390287800_CIT0112","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/j.cgh.2020.10.035","article-title":"Effective treatment of acute severe ulcerative colitis in pregnancy is associated with good maternal and fetal outcomes","volume":"19","author":"Ollech","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2024103011390287800_CIT0113","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/aogs.13775","article-title":"Non-obstetric abdominal surgery during pregnancy and birth outcomes: a Danish registry-based cohort study","volume":"99","author":"Rasmussen","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2024103011390287800_CIT0114","first-page":"1","article-title":"ECCO-ESCP consensus on surgery for Crohn\u2019s Disease","volume":"12","author":"Bemelman","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0115","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/ecco-jcc\/jjz187","article-title":"ECCO guidelines on therapeutics in Crohn\u2019s disease: surgical treatment","volume":"14","author":"Adamina","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0116","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ecco-jcc\/jjab177","article-title":"ECCO guidelines on therapeutics in ulcerative colitis: surgical treatment","volume":"16","author":"Spinelli","year":"2022","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0117","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/MIB.0000000000001112","article-title":"Defining the most appropriate delivery mode in women with inflammatory bowel disease: a systematic review","volume":"23","author":"Foulon","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011390287800_CIT0118","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s10350-007-0240-7","article-title":"The effect of restorative proctocolectomy on sexual function, urinary function, fertility, pregnancy and delivery: a systematic review","volume":"50","author":"Cornish","year":"2007","journal-title":"Dis Colon Rectum"},{"key":"2024103011390287800_CIT0119","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s10350-005-0124-7","article-title":"Vaginal delivery after ileal pouch-anal anastomosis: a word of caution","volume":"48","author":"Remzi","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"2024103011390287800_CIT0120","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cgh.2008.10.022","article-title":"Outcomes of obstetric hospitalizations among women with inflammatory bowel disease in the United States","volume":"7","author":"Nguyen","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2024103011390287800_CIT0121","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/MIB.0000000000000093","article-title":"Impact of mode of delivery on outcomes in patients with perianal Crohn\u2019s disease","volume":"20","author":"Cheng","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011390287800_CIT0122","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/apt.15971","article-title":"Paediatric infections in the first 3 years of life after maternal anti-TNF treatment during pregnancy","volume":"52","author":"Br\u00f6ms","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011390287800_CIT0123","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.crohns.2011.05.006","article-title":"Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease","volume":"5","author":"Ben-Horin","year":"2011","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0124","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/MCG.0b013e31825f2807","article-title":"Infliximab and adalimumab use during breastfeeding","volume":"46","author":"Fritzsche","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"2024103011390287800_CIT0125","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/j.gastro.2015.12.003","article-title":"The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy","volume":"150","author":"Nguyen","year":"2016","journal-title":"Gastroenterology"},{"key":"2024103011390287800_CIT0126","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.gastro.2017.08.067","article-title":"Vedolizumab concentrations in the breast milk of nursing mothers with inflammatory bowel disease","volume":"154","author":"Julsgaard","year":"2018","journal-title":"Gastroenterology"},{"key":"2024103011390287800_CIT0127","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/ecco-jcc\/jjx120","article-title":"Vedolizumab levels in breast milk of nursing mothers with inflammatory bowel disease","volume":"12","author":"Lahat","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0128","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s40262-021-00985-4","article-title":"Vedolizumab concentrations in breast milk: results from a prospective, postmarketing, milk-only lactation study in nursing mothers with inflammatory bowel disease","volume":"60","author":"Sun","year":"2021","journal-title":"Clin Pharmacokinet"},{"key":"2024103011390287800_CIT0129","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/j.gastro.2018.05.040","article-title":"Exposure concentrations of infants breastfed by women receiving biologic therapies for inflammatory bowel diseases and effects of breastfeeding on infections and development","volume":"155","author":"Matro","year":"2018","journal-title":"Gastroenterology"},{"key":"2024103011390287800_CIT0130","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/ecco-jcc\/jjy153","article-title":"Drug levels in the maternal serum, cord blood and breast milk of a ustekinumab-treated patient with Crohn\u2019s disease","volume":"13","author":"Klenske","year":"2019","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0131","first-page":"18","article-title":"Ustekinumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk, and infant serum","volume":"8","author":"Saito","year":"2022","journal-title":"JPHCS"},{"key":"2024103011390287800_CIT0132","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S2468-1253(23)00158-9","article-title":"Tofacitinib concentrations in plasma and breastmilk of a lactating woman with ulcerative colitis","volume":"8","author":"Julsgaard","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2024103011390287800_CIT0133","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.dld.2023.08.054","article-title":"New drugs for the treatment of IBD during conception, pregnancy, and lactation","volume":"56","author":"Pugliese","year":"2023","journal-title":"Dig Liver Dis"},{"key":"2024103011390287800_CIT0134","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/ecco-jcc\/jjy053","article-title":"Hepatitis B vaccination effective in children exposed to anti-tumour necrosis factor alpha in utero","volume":"12","author":"de Lima","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0135","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5217\/ir.2018.00071","article-title":"Influence of anti-tumor necrosis factor-alpha therapy to pregnant inflammatory bowel disease women and their children\u2019s immunity","volume":"17","author":"Lee","year":"2019","journal-title":"Intest Res"},{"key":"2024103011390287800_CIT0136","doi-asserted-by":"crossref","first-page":"935034","DOI":"10.3389\/fped.2022.935034","article-title":"Immune function in newborns with in-utero exposure to anti-TNFalpha therapy","volume":"10","author":"Weiss","year":"2022","journal-title":"Front Pediatr"},{"key":"2024103011390287800_CIT0137","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.cgh.2006.07.018","article-title":"Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn","volume":"4","author":"Vasiliauskas","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2024103011390287800_CIT0138","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1365-2036.2011.04617.x","article-title":"High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy","volume":"33","author":"Zelinkova","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011390287800_CIT0139","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/01.MIB.0000440984.86659.4f","article-title":"Impact of anti-tumor necrosis factor alpha antibodies administered to pregnant women with inflammatory bowel disease on long-term outcome of exposed children","volume":"20","author":"Bortlik","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011390287800_CIT0140","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1007\/s10620-015-3992-2","article-title":"The effect of maternal peripartum anti-TNF\u03b1 use on infant immune response","volume":"61","author":"Sheibani","year":"2016","journal-title":"Dig Dis Sci"},{"key":"2024103011390287800_CIT0141","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cgh.2017.08.041","article-title":"Use of biologic therapy by pregnant women with inflammatory bowel disease does not affect infant response to vaccines","volume":"16","author":"Beaulieu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2024103011390287800_CIT0142","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/ibd\/izy294","article-title":"Safety of anti-TNF-alpha therapy during pregnancy on long-term outcome of exposed children: a controlled, multicenter observation","volume":"25","author":"Duricova","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011390287800_CIT0143","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/INF.0000000000003271","article-title":"Response to vaccination in infants exposed to antitumor necrosis factor alpha in utero","volume":"40","author":"Wieringa","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"2024103011390287800_CIT0144","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/ecco-jcc\/jjad005","article-title":"Vaccines in children exposed to biological agents in utero and\/or during breastfeeding: are they effective and safe","volume":"17","author":"Gisbert","year":"2023","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0145","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3390\/vaccines9050487","article-title":"Vaccines in children with inflammatory bowel disease: brief review","volume":"9","author":"Esposito","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"2024103011390287800_CIT0146","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.3748\/wjg.v23.i42.7644","article-title":"Vaccinations in immunosuppressive-dependent pediatric inflammatory bowel disease","volume":"23","author":"Nguyen","year":"2017","journal-title":"World J Gastroenterol"},{"key":"2024103011390287800_CIT0147","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MPG.0000000000002810","article-title":"Immune response to vaccination in children and young people with inflammatory bowel disease: a systematic review and meta-analysis","volume":"71","author":"Dembi\u0144ski","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024103011390287800_CIT0148","doi-asserted-by":"crossref","first-page":"102676","DOI":"10.1016\/j.jaut.2021.102676","article-title":"Pregnancy and neonatal outcomes in women with immune mediated inflammatory diseases exposed to anti-tumor necrosis factor-\u03b1 during pregnancy: a systemic review and meta-analysis","volume":"122","author":"Barenbrug","year":"2021","journal-title":"J Autoimmun"},{"key":"2024103011390287800_CIT0149","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/ibd\/izab266","article-title":"Safety of immunizations for the adult patient with inflammatory bowel disease \u2013 a systematic review and meta-analysis","volume":"28","author":"Desalermos","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"2024103011390287800_CIT0150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/gutjnl-2014-307127","article-title":"Vedolizumab affects antibody responses to immunisation selectively in the gastrointestinal tract: randomised controlled trial results","volume":"64","author":"Wyant","year":"2015","journal-title":"Gut"},{"key":"2024103011390287800_CIT0151","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1080\/14760584.2021.1875825","article-title":"Immune response and safety of viral vaccines in children with autoimmune diseases on immune modulatory drug therapy","volume":"19","author":"Tse","year":"2020","journal-title":"Expert Rev Vaccines"},{"key":"2024103011390287800_CIT0152","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.crohns.2010.05.001","article-title":"Case report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn\u2019s disease","volume":"4","author":"Cheent","year":"2010","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0153","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/apt.15504","article-title":"Safety of first year vaccination in children born to mothers with inflammatory bowel disease and exposed in utero to anti-TNF\u03b1 agents: a French nationwide population-based cohort","volume":"50","author":"Luu","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2024103011390287800_CIT0154","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/ecco-jcc\/jjaa099","article-title":"Safety and optimal timing of BCG vaccination in infants born to mothers receiving anti-TNF therapy for inflammatory bowel disease","volume":"14","author":"Park","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2024103011390287800_CIT0155","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3389\/fimmu.2017.01123","article-title":"Immunological changes in blood of newborns exposed to anti-TNF-\u03b1 during pregnancy","volume":"8","author":"Esteve-Sol\u00e9","year":"2017","journal-title":"Front Immunol"},{"key":"2024103011390287800_CIT0156","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.dld.2021.05.015","article-title":"Vaccinations in patients with inflammatory bowel disease","volume":"53","author":"Macaluso","year":"2021","journal-title":"Dig Liver Dis"},{"key":"2024103011390287800_CIT0157","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1053\/j.gastro.2020.12.079","article-title":"Canadian Association of Gastroenterology clinical practice guideline for immunizations in patients with inflammatory bowel disease (IBD) \u2013 Part 1: live vaccines","volume":"161","author":"Benchimol","year":"2021","journal-title":"Gastroenterology"},{"key":"2024103011390287800_CIT0158","first-page":"757","article-title":"Live vaccines in children exposed to biological agents for IBD in utero and\/or during breastfeeding: are they safe? Results from the DUMBO registry of GETECCU","volume":"10","author":"Chaparro","year":"2022","journal-title":"UEG Journal"},{"key":"2024103011390287800_CIT0159","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1093\/rheumatology\/keac141","article-title":"A systematic review of live vaccine outcomes in infants exposed to biologic disease modifying anti-rheumatic drugs in utero","volume":"61","author":"Goulden","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2024103011390287800_CIT0160","doi-asserted-by":"crossref","first-page":"17562848211018097","DOI":"10.1177\/17562848211018097","article-title":"The safety of drugs for inflammatory bowel disease during pregnancy and breastfeeding: the DUMBO registry study protocol of GETECCU","volume":"14","author":"Chaparro","year":"2021","journal-title":"Therap Adv Gastroenterol"},{"key":"2024103011390287800_CIT0161","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S2352-4642(23)00136-0","article-title":"Immunological effects and safety of live rotavirus vaccination after antenatal exposure to immunomodulatory biologic agents: a prospective cohort study from the Canadian Immunization Research Network","volume":"7","author":"Fitzpatrick","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"2024103011390287800_CIT0162"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/18\/Supplement_2\/ii16\/60195069\/jjae048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/18\/Supplement_2\/ii16\/60195069\/jjae048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T16:11:38Z","timestamp":1730304698000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/18\/Supplement_2\/ii16\/7848693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":162,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2024,10,30]]},"published-print":{"date-parts":[[2024,10,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjae048","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,10]]}}}